Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 61.99% is in line with its 5-year average of 59.87%, near the high end of its 5-year range (51.11%–65.14%).
0.42% below its 12-month average of 62.25%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 65.14%.
GROSS MARGIN
61.99%
GROSS MARGIN AVG TTM
62.25%
GROSS MARGIN AVG 3Y
61.99%
GROSS MARGIN AVG 5Y
59.87%
GROSS MARGIN AVG 10Y
61.10%
GROSS MARGIN AVG 15Y
61.48%
GROSS MARGIN AVG 20Y
62.33%
CURRENT VS TTM AVG
-0.42%
CURRENT VS 3Y AVG
-0.01%
CURRENT VS 5Y AVG
+3.54%
CURRENT VS 10Y AVG
+1.46%
CURRENT VS 15Y AVG
+0.83%
CURRENT VS 20Y AVG
-0.54%
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+50.44%
vs the sector median at left
KORU Medical Systems, Inc.
Market Cap
$137.80M
Gross Margin
61.99%
TTM Avg
62.25%
3Y Avg
61.99%
5Y Avg
59.87%
Market Cap
$136.67M
Gross Margin
97.90%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$136.57M
Gross Margin
3.67%
TTM Avg
16.70%
3Y Avg
18.97%
5Y Avg
8.54%
Market Cap
$139.04M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
12.53%
5Y Avg
23.21%
Market Cap
$139.47M
Gross Margin
81.26%
TTM Avg
40.63%
3Y Avg
20.32%
5Y Avg
13.54%
Market Cap
$139.84M
Gross Margin
97.20%
TTM Avg
90.61%
3Y Avg
91.14%
5Y Avg
61.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | $137.80M | 61.99% | 62.25% | 61.99% | 59.87% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | 97.90% | 100.00% | 100.00% | 100.00% |
| Organigram Global Inc. (OGI)vs › | $136.57M | 3.67% | 16.70% | 18.97% | 8.54% |
| Immuneering Corporation (IMRX)vs › | $139.04M | 0.00% | 0.00% | 12.53% | 23.21% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | 81.26% | 40.63% | 20.32% | 13.54% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | 97.20% | 90.61% | 91.14% | 61.44% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | 63.13% | 64.40% | 63.36% | 62.40% |
| LifeMD, Inc. (LFMD)vs › | $132.03M | 85.91% | 84.21% | 85.09% | 82.87% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
62.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 65.14% |
| 2026-03-31 | 59.79% |
| 2025-12-31 | 62.57% |
| 2025-09-30 | 60.22% |
| 2025-06-30 | 63.52% |
| 2025-03-31 | 62.75% |
| 2024-12-31 | 62.94% |
| 2024-09-30 | 63.40% |
| 2024-06-30 | 65.00% |
| 2024-03-31 | 62.25% |
| 2023-12-31 | 60.27% |
| 2023-09-30 | 62.00% |
| 2023-06-30 | 56.06% |
| 2023-03-31 | 56.10% |
| 2022-12-31 | 55.53% |
| 2022-09-30 | 55.70% |
| 2022-06-30 | 51.11% |
| 2022-03-31 | 58.01% |
| 2021-12-31 | 59.04% |
| 2021-09-30 | 57.87% |
| 2021-06-30 | 58.07% |
| 2021-03-31 | 59.51% |
| 2020-12-31 | 56.62% |
| 2020-09-30 | 64.81% |
| 2020-06-30 | 63.69% |
| 2020-03-31 | 59.85% |
| 2019-12-31 | 63.44% |
| 2019-09-30 | 66.23% |
| 2019-06-30 | 64.98% |
| 2019-03-31 | 61.27% |
| 2018-12-31 | 63.53% |
| 2018-09-30 | 63.59% |
| 2018-06-30 | 60.85% |
| 2018-03-31 | 61.14% |
| 2017-12-31 | 64.15% |
| 2017-09-30 | 61.79% |
| 2017-06-30 | 59.99% |
| 2017-02-28 | 54.49% |
| 2016-11-30 | 64.64% |
| 2016-08-31 | 62.09% |
| 2016-05-31 | 64.77% |
| 2016-02-29 | 59.57% |
| 2015-11-30 | 67.07% |
| 2015-08-31 | 63.38% |
| 2015-05-31 | 57.70% |
| 2015-02-28 | 56.41% |
| 2014-11-30 | 59.51% |
| 2014-08-31 | 65.33% |
| 2014-05-31 | 57.88% |
| 2014-02-28 | 61.33% |
| 2013-11-30 | 60.79% |
| 2013-08-31 | 59.77% |
| 2013-05-31 | 62.30% |
| 2013-02-28 | 63.33% |
| 2012-11-30 | 62.19% |
| 2012-08-31 | 65.86% |
| 2012-05-31 | 63.46% |
| 2012-02-29 | 69.07% |
| 2011-11-30 | 60.74% |
| 2011-08-31 | 63.80% |
| 2011-05-31 | 63.84% |
| 2011-02-28 | 67.81% |
| 2010-11-30 | 67.22% |
| 2010-08-31 | 66.06% |
| 2010-05-31 | 63.03% |
| 2010-02-28 | 69.96% |
| 2009-11-30 | 65.51% |
| 2009-08-31 | 67.72% |
| 2009-05-31 | 61.56% |
| 2009-02-28 | 66.12% |
| 2008-11-30 | 63.34% |
| 2008-08-31 | 66.06% |
| 2008-05-31 | 64.47% |
| 2008-02-29 | 60.71% |
| 2007-11-30 | 63.56% |
| 2007-08-31 | 68.67% |
| 2007-05-31 | 49.77% |
| 2007-02-28 | 67.28% |
| 2006-11-30 | 56.18% |
| 2006-08-31 | 65.22% |
| 2006-05-31 | 56.77% |
| 2006-02-28 | 55.14% |
| 2005-11-30 | 65.32% |
| 2005-08-31 | 59.00% |
| 2005-05-31 | 53.27% |
| 2005-02-28 | 50.62% |
| 2004-11-30 | 52.42% |
| 2004-08-31 | 52.56% |
| 2004-05-31 | 56.69% |
| 2004-02-29 | 51.45% |
| 2003-11-30 | 52.95% |
| 2003-08-31 | 52.22% |
| 2003-05-31 | 53.75% |
| 2003-02-28 | 80.46% |
| 2002-11-30 | 31.82% |
| 2002-08-31 | 32.73% |
